Globus Medical (GMED) Reports In-Line Q2 EPS

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $137.5 million versus the consensus estimate of $141.78 million.

GUIDANCE:

Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus Medical sees FY2016 revenue of $575 million, versus the consensus of $583.1 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• SPS Commerce (SPSC) Tops Q1 EPS by 12c
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c